US2015283140A1PendingUtilityA1
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Est. expiryMar 27, 2026(expired)· nominal 20-yr term from priority
A61K 45/06A61K 31/517A61K 31/475A61K 31/52A61K 31/519A61K 31/337A61P 25/02A61P 29/00A61K 31/529A61P 25/00A61K 33/24A61K 33/243
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention refers to the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogues/derivatives as well as their acceptable salts, for the production of a medicament for the treatment of neuropathic pain resulting from chemotherapy.
Claims
exact text as granted — not AI-modified1 . Use of a sodium channel blocker and/or its derivatives, optionally in the form of its racemate, pure stereoisomers, especially enantiomers or diastereomers or in the form of mixtures of stereoisomers, especially enantiomers or diastereomers, in any suitable mixing ratio; in neutral form, in the form of an acid or base or in form of a salt, especially a physiologically acceptable salt, or in form of a solvate, especially a hydrate for the production of a medicament for the treatment of neuropathic pain developing as a consequence of chemotherapy.
2 - 28 . (canceled)Join the waitlist — get patent alerts
Track US2015283140A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.